MFDS
- Status: likely_approved
🇰🇷 Augmentin 250 in South Korea
Augmentin 250 (CLAVULANIC ACID) regulatory status in South Korea.
Marketing authorisation
Augmentin 250 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Augmentin 250 approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Augmentin 250 in South Korea?
Dr Reddys Labs Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.